Hemoglobin A1C Analyzer Market

Hemoglobin is a protein found in the red blood cells. Its job is to carry oxygen from the lungs to all other parts of the body. Hemoglobin also has the ability to bind with glucose in the bloodstream; this type of bonding is called glycation.

The glycation process is irreversible so glycated hemoglobin (HbA1c) remains in its evolved state for the lifespan of the red blood cell - approximately 8-12 weeks. By measuring the amount of HbA1c in the blood it is possible to determine average blood glucose control over an 8-12 week period. The more HbA1c in your blood, the less controlled a patient?s diabetes is and the more susceptible they are to developing long-term health complications.

HbA1c levels, which reflect the average plasma glucose concentration over the preceding three months, play a pivotal role in the diagnosis, assessment, and monitoring of diabetes.

The immediate feedback of HbA1c levels is highly effective for controlling plasma glucose levels.

Hemoglobin A1C Analyzer Market contains market size and forecasts of Hemoglobin A1C Analyzer in global, including the following market information:

Global Hemoglobin A1C Analyzer Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Hemoglobin A1C Analyzer Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Hemoglobin A1C Analyzer companies in 2021 (%)

The global Hemoglobin A1C Analyzer market was valued at 1648.5 million in 2021 and is projected to reach US$ 2975.8 million by 2028, at a CAGR of 8.8% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Bench-top Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hemoglobin A1C Analyzer include Abbott Laboratories, Roche, Siemens, Bio-Rad Laboratories, Tosoh, Danaher Corporation, Trinity Biotech, HUMAN Diagnostics and Arkray and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Hemoglobin A1C Analyzer manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hemoglobin A1C Analyzer Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hemoglobin A1C Analyzer Market Segment Percentages, by Type, 2021 (%)

Bench-top

Compact

Portable

Global Hemoglobin A1C Analyzer Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hemoglobin A1C Analyzer Market Segment Percentages, by Application, 2021 (%)

Hospital

Homecare

Others

Global Hemoglobin A1C Analyzer Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hemoglobin A1C Analyzer Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hemoglobin A1C Analyzer revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Hemoglobin A1C Analyzer revenues share in global market, 2021 (%)

Key companies Hemoglobin A1C Analyzer sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Hemoglobin A1C Analyzer sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Abbott Laboratories

Roche

Siemens

Bio-Rad Laboratories

Tosoh

Danaher Corporation

Trinity Biotech

HUMAN Diagnostics

Arkray

OSANG Healthcare